EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Immunopeptidomics in gliomas: Decoding antigen presentation for precision immunotherapy

Georgios Kallivokas, Vasileia-Rafaella Karmaniola, Panagiotis G Vrettos, Eleni-Kyriaki Vetsika, Christina Piperi

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026

DOI: 10.1016/j.bbcan.2026.189701 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Georgios Kallivokas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic and Clinical Sciences, Medical School, University of Nicosia, UNIC Athens, 167 77 Athens, Greece; Centre of New Biotechnologies a…. Hauptthemen laut MEDLINE: Immunotherapy, Antigens, Neoplasm, Glioma, Antigen Presentation. Die Arbeit nennt 106 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gliomas and particularly glioblastomas, represent the most aggressive and treatment-resistant brain tumours. Current standard treatments, including surgical resection, radiotherapy and chemotherapy, offer only limited long-term survival benefits. The highly immunosuppressive tumour microenvironment that characterizes gliomas enables immune evasion and limits the effectiveness of anti-tumour immune response, indicating the urgent need for identification of tumour antigens with clinical relevance to improve current immunotherapeutic strategies and enhance glioma immunogenicity. Immunopeptidomics, a mass spectrometry-based identification of peptides presented by HLA molecules, is a growing field of research for understanding the immunosurveillance of gliomas. By enabling the direct identification of naturally presented HLA-bound peptides from tumour tissue for T cell recognition, immunopeptidomics provide valuable insights into tumour antigen presentation and immune targeting. This review highlights the emerging role of immunopeptidomics in gliomas, covering the mechanisms of antigen processing and presentation by HLA class I and II molecules, the identification of glioma-associated antigens, the development of personalised peptide vaccines and the discovery of new targets for T cell-based immunotherapies. The potential of plasma-derived soluble HLA (sHLA) peptidomes as minimally invasive liquid-biopsy biomarkers is further discussed for disease monitoring and response to treatment. Overall, immunopeptidomics are foreseen as a powerful tool for the discovery of new tumour antigens leading to the development of more effective personalised glioma immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyAntigens, NeoplasmGliomaAntigen PresentationBrain NeoplasmsProteomicsPeptidesHumansTumor MicroenvironmentPrecision MedicineAnimalsT-Lymphocytes

Stichwörter der Autor:innen

AntigensBrain tumoursHLALiquid biopsiesPeptidomicsTumour microenvironment

Substanzen

Antigens, NeoplasmPeptides

Autor:innen und Institutionen

  • Department of Basic and Clinical Sciences, Medical School, University of Nicosia, UNIC Athens, 167 77 Athens, Greece; Centre of New Biotechnologies and Precision Medicine (CNBPM), School of Medicine, National and Kapodi…
  • Department of Basic and Clinical Sciences, Medical School, University of Nicosia, UNIC Athens, 167 77 Athens, Greece.
  • Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece. Electronic address: cpiperi@med.uoa.gr.

Zitieren

APA

Kallivokas, G., Karmaniola, V. R., Vrettos, P. G., Vetsika, E. K., & Piperi, C. (2026). Immunopeptidomics in gliomas: Decoding antigen presentation for precision immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2026.189701

Vancouver

Kallivokas G, Karmaniola VR, Vrettos PG, Vetsika EK, Piperi C. Immunopeptidomics in gliomas: Decoding antigen presentation for precision immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2026.189701

BibTeX
@article{Kallivokas2026,
  author = {Kallivokas, Georgios and Karmaniola, Vasileia-Rafaella and Vrettos, Panagiotis G and Vetsika, Eleni-Kyriaki and Piperi, Christina},
  title = {Immunopeptidomics in gliomas: Decoding antigen presentation for precision immunotherapy},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  doi = {10.1016/j.bbcan.2026.189701}
}
Kostenlos starten →